Assessment of Chemotherapy Response Using FDG-PET in Pediatric Bone Tumors: A Single Institution Experience
Dong Hwan Kim, Seung Yeon Kim, Hyeon Jeong Lee, Bong Sup Song, Dong Ho Kim, Joong Bum Cho, Jung Sub Lim, Jun Ah Lee
Cancer Res Treat. 2011;43(3):170-175.   Published online 2011 Sep 30     DOI: https://doi.org/10.4143/crt.2011.43.3.170
Citations to this article as recorded by Crossref logo
18F-FDG PET/CT in the Management of Osteosarcoma
Chiwoo Oh, Michael W. Bishop, Steve Y. Cho, Hyung-Jun Im, Barry L. Shulkin
Journal of Nuclear Medicine.2023; 64(6): 842.     CrossRef
[18F]FDG PET/CT quantitative parameters for the prediction of histological response to induction chemotherapy and clinical outcome in patients with localised bone and soft-tissue Ewing sarcoma
Alessio Annovazzi, Virginia Ferraresi, Vincenzo Anelli, Renato Covello, Sabrina Vari, Carmine Zoccali, Roberto Biagini, Rosa Sciuto
European Radiology.2021; 31(9): 7012.     CrossRef
Different 18F‐FDG PET parameters for the prediction of histological response to neoadjuvant chemotherapy in pediatric Ewing sarcoma family of tumors
Gihan El‐Hennawy, Hosna Moustafa, Walid Omar, Naglaa Elkinaai, Ahmad Kamel, Iman Zaki, Nesma Farid, Esraa El‐Kholy
Pediatric Blood & Cancer.2020;[Epub]     CrossRef
Sarcomes osseux
J.L. Albérini, P.Y. Salaün
Médecine Nucléaire.2019; 43(1): 138.     CrossRef
Diagnostic Accuracy of 18F-FDG PET/CT in the Staging and Assessment of Response to Chemotherapy in Children With Ewing Sarcoma
Antonio Ruggiero, Valerio Lanni, Alberto Librizzi, Palma Maurizi, Giorgio Attinà, Stefano Mastrangelo, Alessandro Giordano, Riccardo Riccardi
Journal of Pediatric Hematology/Oncology.2018; 40(4): 277.     CrossRef
The role of 18F-FDG PET/CT in the detection of osteosarcoma recurrence
Andrea Angelini, Francesco Ceci, Paolo Castellucci, Tiziano Graziani, Giulia Polverari, Giulia Trovarelli, Emanuela Palmerini, Stefano Ferrari, Stefano Fanti, Pietro Ruggieri
European Journal of Nuclear Medicine and Molecular Imaging.2017; 44(10): 1712.     CrossRef
PET/CT of Osteosarcoma and Ewing Sarcoma
Colleen M. Costelloe, Hubert H. Chuang, Najat C. Daw
Seminars in Roentgenology.2017; 52(4): 255.     CrossRef
Qualitative and Semi-Quantitative 18-F FDG PET/CT for Osteosarcoma: A Review
Lorenzo Nardo, Michelle Zhang, Luca Facchetti, Benjamin L. Franc
Current Radiology Reports.2017;[Epub]     CrossRef
Tumour hypoxia: lessons learnt from preclinical imaging
Isabella Raccagni, Silvia Valtorta, Rosa Maria Moresco, Sara Belloli
Clinical and Translational Imaging.2017; 5(5): 407.     CrossRef
Assessment of response to treatment in paediatric bone sarcomas by means of PET imaging
Natale Quartuccio, Byung Hyun Byun, Pierpaolo Alongi, Federico Caobelli, Chang-Bae Kong, Sang Moo Lim, Angelina Cistaro
Clinical and Translational Imaging.2016; 4(1): 41.     CrossRef
Modern Methods of Visualization in Diagnosis, Staging and Elaboration of Treatment Tactics for Primary Malignant Bone Tumors. Part I
G. N. Machak, A. K. Morozov, A. I. Snetkov, I. N. Karpov, N. V. Kochergina, A. B. Bludov, A. D. Ryzhkov
Vestnik travmatologii i ortopedii imeni N.N. Priorova.2016; (3): 53.     CrossRef
Modern Methods of Visualization in Diagnosis, Staging and Elaboration of Treatment Tactics for Primary Malignant Bone Tumors. Part I
G. N Machak, A. K Morozov, A. I Snetkov, I. N Karpov, N. V Kochergina, A. B Bludov, A. D Ryzhkov
N.N. Priorov Journal of Traumatology and Orthopedics.2016; 23(3): 53.     CrossRef
Radiotherapy and gemcitabine–docetaxel chemotherapy in children and adolescents with unresectable recurrent or refractory osteosarcoma
Jun Ah Lee, Eun Kyung Paik, Juhee Seo, Dong Ho Kim, Jung Sub Lim, Ji Young Yoo, Mi-Sook Kim
Japanese Journal of Clinical Oncology.2015; : hyv171.     CrossRef
Tumor‐to‐background Ratio to Predict Response to Chemotherapy of Osteosarcoma Better than Standard Uptake Values
Jin‐peng He, Yun Hao, Mi Li, Jiang Wang, Feng‐jin Guo
Orthopaedic Surgery.2014; 6(2): 145.     CrossRef
Targeting receptor tyrosine kinases in osteosarcoma and Ewing sarcoma: Current hurdles and future perspectives
Emmy D.G. Fleuren, Yvonne M.H. Versleijen-Jonkers, Otto C. Boerman, Winette T.A. van der Graaf
Biochimica et Biophysica Acta (BBA) - Reviews on Cancer.2014; 1845(2): 266.     CrossRef
FDG PET/CT of Primary Bone Tumors
Colleen M. Costelloe, Hubert H. Chuang, John E. Madewell
American Journal of Roentgenology.2014; 202(6): W521.     CrossRef
Atypical growth on MRI in a case of Ewing’s sarcoma despite lower SUV on PET
Zachary Sanford, Stanford Israelsen, Rajesh Sehgal, Felix H. Cheung
Skeletal Radiology.2014; 43(6): 819.     CrossRef
Characterization of Different Osteosarcoma Phenotypes by PET Imaging in Preclinical Animal Models
Carmen Campanile, Matthias J.E. Arlt, Stefanie D. Krämer, Michael Honer, Ana Gvozdenovic, Patrick Brennecke, Cindy R. Fischer, Adam A. Sabile, Adrienne Müller, Simon M. Ametamey, Walter Born, Roger Schibli, Bruno Fuchs
Journal of Nuclear Medicine.2013; 54(8): 1362.     CrossRef
Promise and pitfalls of quantitative imaging in oncology clinical trials
Brenda F. Kurland, Elizabeth R. Gerstner, James M. Mountz, Lawrence H. Schwartz, Christopher W. Ryan, Michael M. Graham, John M. Buatti, Fiona M. Fennessy, Edward A. Eikman, Virendra Kumar, Kenneth M. Forster, Richard L. Wahl, Frank S. Lieberman
Magnetic Resonance Imaging.2012; 30(9): 1301.     CrossRef
18F NaF PET/CT in the Assessment of Malignant Bone Disease
Camila Mosci, Andrei Iagaru
PET Clinics.2012; 7(3): 263.     CrossRef
The Role of Fluorine-18-fluorodeoxyglucose Positron Emission Tomography in Assessing the Response to Neoadjuvant Treatment in Patients with Osteosarcoma
Carmelo Caldarella, Marco Salsano, Maria Antonietta Isgrò, Giorgio Treglia
International Journal of Molecular Imaging.2012; 2012: 1.     CrossRef